July 16, 2024

		

Jorge Mercado

Jorge Mercado is a staff writer with the Business Times. His beats include technology, agriculture, cannabis, energy and the environment, and higher education.


| Thursday, January 4th, 2024

MannKind looks to clear up debt with capital from royalty agreement

Health Care & Life Science, Latest news, middle, Subscriber content, Tri-County Economy, Tri-County Public Companies

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

| Thursday, January 4th, 2024

Region’s top stocks look to dominate their industries

Central Coast, Latest news, left, Subscriber content, Tri-County Economy, Tri-County Public Companies

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

| Tuesday, January 2nd, 2024

MannKind inks royalty purchase agreement for up to $200M

Central Coast, Health Care & Life Science, Latest news, Top Stories, Top Story

Westlake Village-based MannKind Corporation saw shares climb 8% on Jan. 2 after the company announced entering into a royalty purchase agreement of up to $200 million. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, sold a 1% royalty in net sales of Tyvaso DPI to Sagard Healthcare on Dec. 27. Read More →

| Tuesday, December 26th, 2023

CRE: Two multi-family apartments in Thousand Oaks sold for $171M

Columns, Latest news, Real Estate, Subscriber content

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

| Friday, December 22nd, 2023

Arcutis’ treatment gets additional FDA approval

Health Care & Life Science, Latest news, Subscriber content, Top Stories, Top Story, Tri-County Economy

Westlake Village-based Arcutis Biotherapeutics announced that its main treatment option, Zoryve, received approval from the U.S. Drug and Food Administration for treating a skin condition called seborrheic dermatitis, the company announced on Dec. 15 It is the second FDA approval received by Arcutis’ Zoryve, being approved to be used in individuals nine years of age Read More →

| Thursday, December 21st, 2023

Cottage, independent physicians partner to open new surgery center

Health Care & Life Science, Latest news, middle, Subscriber content

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

| Tuesday, December 19th, 2023

Atara to cut workforce by 30%, will keep T.O. locations operational

Latest news, Subscriber content, Technology, Top Stories, Top Story, Tri-County Economy, Ventura County

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.